Counting to Four $25.537M Market Capitalization Filament Health Corp. (FH.NE) announced today that it has been issued a fourth patent for the extraction and standardization of natural psilocybin and…
invest in psychedelics
Two for Two $23.066M Market Capitalization Filament Health Corp. (FH.NE) announced today that it has been issued a second patent by the Canadian Intellectual Property Office (CIPO) for the…
Problematic Psychedelics? Psychedelics and mental health treatment go together like orange juice and toothpaste. That’s what I would have said five years ago. Prior to the publication of multiple…
Cheap financings Startups, both private and public have a myriad of options when it comes to raising capital. One method that’s gained a lot of traction over the last…
Pubco failure Microdosing was the biggest buzzword in the psychedelics sector only 2 years ago, but nowadays it’s rarely discussed, at least in terms of publicly traded companies. HAVN…
In a groundbreaking story MindMed (MNMD.Q) announced today has been granted approval by the Swiss Ethics Committee to evaluate the acute effects of different doses of mescaline and the…
“Say something, goddammit! You are on television! You’re live to the whole world!” – The Truman Show After multiple attempts at writing a story on HAVN Life Sciences (HAVN.C)…